NLRP3 and injury: Recent evidence showed that, in an in vitro SH SY5Y model and an in vivo model of cerebral trauma induced by PTZ, the administration of MCC950 significantly provided a protective effect, and reduced epileptic neuronal apoptosis by inhibiting NLRP3 inflammasome activation [72].